AIM
AMPE

Acrospire Investment Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Acrospire Investment Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-13
Closed -$5K – 2225
2016
Q2 		$5K Buy
+13
New +$14.2K ﹤0.01% 1870

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 28.54% 1-Year Est. Return

Acrospire Investment Management's AMPE Position: Q3 2016 in Review

Acrospire Investment Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2016, closing a stake of 13 shares — an estimated $5K sold.

Acrospire Investment Management first reported a position in AMPE in Q2 2016 and held it in 1 quarter. The position peaked at $5K in Q2 2016. 71 funds tracked by Wall St. Rank hold AMPE as of Q3 2016.

  • Acrospire Investment Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 13 Ampio Pharmaceuticals Inc. shares in Q3 2016, an estimated $5K.
  • Acrospire Investment Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2016 and held it in 1 quarter.
  • Acrospire Investment Management's Ampio Pharmaceuticals Inc. position peaked at $5K in Q2 2016.
  • 71 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2016.

Based on Acrospire Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.